Join us for the ESMO Targeted Anticancer Therapies Congress 2025, taking place on March 3-5 in Paris, France. It is organized by the European Society for Medical Oncology.

This essential multi-stakeholder forum brings together researchers, industry partners, investors, and regulatory bodies, creating a unique opportunity for professionals involved in the development of new anticancer drugs.

This is a fantastic chance to connect in Paris, share the latest data, foster collaboration, and tackle the challenges we face in accelerating the path from bench to bedside for the benefit of our patients. Don’t miss out on being part of this important conversation!

Register here.

Find more information featuring ESMO at OncoDaily.com.